CELZ — Creative Medical Technology Holdings Balance Sheet
0.000.00%
- $5.17m
- -$0.77m
- $0.01m
- 29
- 20
- 36
- 18
Annual balance sheet for Creative Medical Technology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.098 | 10.7 | 18.4 | 9.99 | 5.94 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 0.002 | 0 | — | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.098 | 10.7 | 18.7 | 10.3 | 6.14 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.718 | 11.3 | 19.2 | 10.7 | 6.67 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 40.5 | 1.05 | 3.32 | 0.371 | 0.328 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 40.5 | 1.05 | 3.32 | 0.371 | 0.328 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | -39.8 | 10.2 | 15.9 | 10.3 | 6.34 |
Total Liabilities & Shareholders' Equity | 0.718 | 11.3 | 19.2 | 10.7 | 6.67 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |